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Dynabeads (diameter 4.5 µm) and iron powder (diameter 6 µm). Tissues were then rinsed on a 70 µm nylon mesh after magnetic treatment to remove small tubular fragments.
Podocyte Culture
The MPC5 conditionally immortalized mouse podocyte cell line was kindly provided by Dr. Yong Gu (Department of Nephrology, Huashan Hospital of Fudan University, Shanghai, China) and their cell lines were provided by Dr. Peter Mundel (Mount Sinai School of Medicine, New York, NY, USA) and were cultured as previously described [18] . Podocytes were maintained without interferon-γ at 37℃ for 14 days before experimentation to induce differentiation. Differentiated podocytes were made quiescent in medium that contained 0.1% FBS for 24 h, then cells exposed to treatment for the indicated time periods.
Transient transfection of cells with siRNA
For knockdown experiments, podocyte cells were transiently transfected with siRNA specifically targeting Cx43 or a negative control siRNA using Lipofectamine PLUS (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Cells were transfected with 20 nM Cx43 siRNA or control siRNA for 24 h before further treatment. Cellular protein was extracted and subjected to Western blot analysis for Cx43.
Apoptosis Studies Analysis of podocyte apoptosis in vitro.
The cytosolic DNA-histone complexes generated during apoptotic DNA fragmentation in treated podocytes were evaluated with a cell death detection ELISA kit (Cell Death Detection ELISA PLUS; Roche Applied Science, Indianapolis, IN, USA) and performed following the supplier's instructions.
Analysis of podocyte apoptosis in renal tissue. Apoptotic cells were detected on kidney section using a terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay (Roche Molecular Biochemicals) following the manufacturer's protocol.
Immunofluorescence staining
Indirect immunofluorescence staining was performed according to an established procedure. Briefly, cryosections of 3 μm thickness were prepared. After being blocked with 3% BSA (bovine serum albumin) for 1 h, the sections were incubated with primary antibodies against Cx43 and Nephrin (sc-377246, Santa Cruz) in PBS containing 3% BSA overnight at 4℃, Sections were then washed in PBS and incubated in the dark with FITC and TRITC-conjugated secondary antibodies (Sigma-Aldrich) at a 1:200 dilution in PBS containing 3% BSA for 1 h. After being thoroughly washed with PBS, slides were mounted with 4',6-diamidino-2-phenylindole (DAPI, Vector Laboratories, H-1200) and viewed with a Nikon Eclipse 80i Epi-fluorescence microscope equipped with a digital camera (DS-Ri1, Nikon).
Localization of Cx43 in podocytes by immunofluorescence
Podocytes were treated with Aldo (10 -7 M) for 24 h. After fixation with cold acetone for 10 min, the cells were blocked at room temperature with 5% BSA for 40 min. The cells were then incubated with 5% BSA (Negative control) or anti-Cx43 (Control and Aldo), respectively, followed by staining with TRITCconjugated secondary antibodies. Finally, cells were double stained with DAPI and viewed with a Nikon Eclipse 80i Epi-fluorescence microscope equipped with a digital camera (DS-Ri1, Nikon).
DCFDA fluorescence detection of ROS
Podocyte ROS production was measured as previously described [19] . Relative fluorescence was detected using a fluorescence plate reader at the excitation/emission wavelengths of 485 and 535 nm, respectively.
Scrape Load Dye Transfer Technique (SLDT)
SLDT was used to assess GJIC activity [20] . Briefly, podocytes on coverslips at 90% confluence were rinsed three times with PBS containing 0.01% Ca 2+ and Mg
2+
. 1.5 mL of PBS containing 0.5% fluorescent dye (Lucifer yellow; Molecular Probes) was then added to the coverslips and a scalpel was used to scrape a cross through the monolayer. The cells were incubated for 3 minutes at room temperature and then rinsed again with PBS containing 0.01% Ca 2+ and Mg 
Western blot analysis
Podocytes harvested from plates and sieved glomeruli were lysed in SDS sample buffer containing 150 mM NaCl, 0.1% Triton X-100, 0.5% Deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 50 mM Tris-HCl (pH 7.0), and 1 mM ethylenediaminetetraacetic acid (EDTA). Detection of protein expression by Western blot was carried out according to established protocols. The primary antibodies used were as follows: Cx43 (1:1000), Bax (1:1000), Bcl-2 (1:1000), and β-actin (1:1000). Densitometric analysis was performed using Quantity One Software (Bio-Rad).
Statistical Analyses
Data are expressed as the mean ± SD. Comparisons between groups were performed with oneway ANOVA followed by Dunnett's multiple comparison tests or Student's t-test. P<0.05 was considered statistically significant.
Results

Clinical characteristics and renal function
The kidney-to-body weight ratio, urine volume, urinary albumin/creatinine, ending urinary Aldo, and blood pressure were all significantly increased in the Aldo group compared to control rats. However, there were no significant differences in body weight and creatinine clearance between the two groups ( Table 1) .
Aldo induced podocytes injury in vivo
To determine whether podocyte apoptosis was increased following treatment with Aldo, the number of TUNEL-positive podocytes per glomerular cross-section was evaluated. Our results indicated that Aldo significantly increased podocyte apoptosis compared with the control group (P <0.05) ( Fig. 1A and B) . Given the increase in TUNEL-positive cells in Aldo treated rats, immunostaining for Wilms's tumor protein (WT-1), a surrogate marker for podocyte number, was performed to determine if the decrease in WT-1-positive cells was secondary to apoptosis. Compared with the control group (15.6±1.3), the number of podocytes was significantly decreased in Aldo infused rats (8.4±0.9) (Fig. 1C and D) . Taken together, these results indicate that Aldo induces podocyte injury in vivo.
Aldo increased podocytes Cx43 protein expression in vivo
Double-immunofluorescent staining assays and western blot were used to examine the expression of Cx43 in kidney tissues. Based on visual inspection of the co-localization of Cx43 with nephrin, our results demonstrate that the expression of Cx43 is significantly increased in Aldo-infused rats, mainly due to their increases in podocytes, when compared to the control group (P < 0.01) ( Fig. 2A and B) .
Aldo Increased apoptosis in Cultured Mouse Podocytes
Compared with the control group, the addition of Aldo for 24 h increased podocyte apoptosis in a dose-dependent manner at concentrations ranging from 10 -9 to 10 -7 M (P < 0.01, Fig. 3A ). Since the maximal induction was found at 10 -7 M Aldo treatment, we therefore used 10 -7 M in most of our cell experiments. As shown in Fig. 3B , 10 -7 M Aldo induced apoptosis of podocytes in a time-dependent manner.
Aldo Increased Cx43 gene expression and GJIC in Cultured Mouse Podocytes
Cultured podocytes stimulated with Aldo up-regulated expression of Cx43 in a dosedependent and time-dependent manner (P < 0.01, Fig. 4A and B) . Immunofluorescent # P < 0.05 with respect to the control group.
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staining also indicated that 10 -7 M Aldo increased Cx43 expression (Fig. 4C ). In addition, 10
M Aldo stimulation increased the GJIC in cultured podocytes (Fig. 4D) . 
Increased ROS production and Bax/Bcl-2 ratio is involved in Aldo-induced Podocytes apoptosis
Since increased levels ROS and the proteins of the Bcl-2 family are considered to be the major apoptotic signal transduction cascades associated with programmed cell death, we examined the production of ROS and the expression of Bcl-2 and Bax in cells treated with Aldo for 24 h (Fig. 5A) . Compared with the control group, 10 -7 M Aldo increased ROS generation (Fig. 5A ) and the Bax/Bcl-2 ratio (Fig. 5B) . However, treatment with NAC decreased the DCF fluorescence and Bax/Bcl-2 ratio, attenuating the Aldo-induced apoptosis (Fig. 5A, B , and C). Thus, increasing the ROS production and the ratio of Bax/Bcl-2 may contribute to the susceptibility of podocytes to Aldo-induced apoptosis (P < 0.05).
Silencing Cx43 expression inhibited the Aldo-induced apoptosis of podocytes by a reduction in ROS production and down-regulation of Bax/Bcl-2 ratio
To explore the role of Cx43 gene in Aldo-induced apoptosis of podocytes, we transfected podocytes with either siRNA-Cx43 or nonsense siRNA-con as a control. After 24 h, Cx43 expression was assessed by western blot analysis. Our results indicate that Cx43 protein levels were markedly lower in podocytes transfected with siRNA-Cx43 than those of control podocyte and podocyte transfected with siRNA-con (Fig. 6A) . Moreover, Cx43 silencing inhibited the production of ROS, down-regulated the ratio of Bax/Bcl-2, and partially attenuated the Aldo-induced apoptosis of podocytes (Fig. 6 B, C and D) . 
Discussion
In the present study, we investigated the role of Cx43 in Aldo-induced podocyte injury. In vivo studies demonstrated that Aldo infusion significantly increased SBP, the kidney/body weight ratio, and the urinary protein/creatinine ratio. Additionally, renal cortical sections of Aldo-infused rats showed a greater numbers of TUNEL-positive podocytes, reduced WT1-positive podocytes, and an increase in Cx43 expression. In vitro studies indicated that Aldo induced podocyte apoptosis in a dose-and time-dependent manner, accompanied by increases in Cx43 expression, ROS production, and the Bax/Bcl-2 ratio. Silencing Cx43 expression could attenuate podocyte apoptosis, which is mediated through the reduction of ROS production and the subsequent down-regulation of the Bax/Bcl-2 ratio.
Aldo, an important hormone, is associated with albuminuria [21] , hypertension [22] and glomerulosclerosis [23] . Epidemiological studies have shown a beneficial effect of MR inhibitors on patient outcomes compared to placebo control [24, 25] . Aldo-induced apoptotic cell loss plays a critical role in the pathophysiology of kidney failure, and has recently attracted considerable attention from many kidney disease scholars. Aldo has been shown to cause tubular epithelial and mesangial cell apoptosis by affecting the mitochondrial [26, 27] . Consistent with previous studies [28, 29] , our results indicate that Aldo induced podocyte injury both in vivo and in vitro ( Fig. 1 and 3) . Recently, growing evidence has shown that Cx43 might be involved in the process of podocyte injury in kidney pathology, including hypertension and diabetes nephropathy [13, 30] . Our in vitro and in vivo data has demonstrated that the treatment with Aldo could also elevate the expression of Cx43 in podocytes (Fig. 2 and 4A through C) . In addition, GJIC was augmented in Aldo-induced podocytes (Fig. 4D) , which may facilitate the spread of apoptotic signals. Interestingly, after silencing Cx43 expression, Aldo-induced apoptosis in cultured podocytes was partially attenuated, suggesting Cx43 was partially involved in Aldo-induced podocyte apoptosis and targeting of Cx43 could protect podocytes from Aldo-induced apoptosis ( Fig. 6A and B) .
Reactive oxygen species (ROS) also play a key role in the progression of renal injury [31, 32] . Nishiyama et al [33] demonstrated that renal injury was associated with increased renal cortical ROS levels in Aldo/salt hypertensive rats. Consist with these previous studies [4] , our data showed that Aldo increased the generation of ROS in cultured podocytes. As expected, pretreatment with NAC, a free radical scavenger, prevented the elevation of ROS levels and ameliorated renal injury ( Fig. 5A and C) . After silencing Cx43 expression, the Aldo-induced increased the generation of ROS by was partially inhibited, indicating that impairment of Cx43-coupling attenuates Aldo-induced podocyte apoptosis through inhibition of ROS generation ( Fig. 6 B and C) .
Aldo-induced increase of ROS production is thought to be the main reason for uncontrolled oxidative stress, which can lead to changes in expression of Bcl-2 and Bax (markers of mitochondrial dysfunction) [34] . An increase in the levels of pro-apoptotic proteins (Bax) and/or a decrease in the levels of apoptotic inhibitors (Bcl-2), is a key event in the induction of apoptosis [35] [36] [37] . Consistent with previous reports, in our study, we found that treatment of podocytes with Aldo resulted in a reduction in the levels of the antiapoptotic protein Bcl-2 with a concomitant increase in the levels of the pro-apoptotic protein Bax when compared to the control podocytes (Fig. 5B) . However, silencing Cx43 expression partially attenuated these changes, and may partially be responsible for the induction of apoptosis (Fig. 6 B and D) .
Conclusion
In conclusion, our study provides evidence that Aldo-mediated upregulation of Cx43 expression, GJIC activity, and the following increase in ROS production and the Bax/Bcl-2 ratio is partially involved in podocyte injury. Cx43 might be a potential therapeutic target for the treatment of CKD.
